Lyophitech specializes in freeze-drying technology for the microbiology and probiotics sectors, enhancing the stability and shelf-life of sensitive biological products. The company addresses the challenge of preserving microbial viability during storage and transport, ensuring that probiotics maintain their efficacy for the food industry.
Funding
$3.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many biological products, especially in the microbiology and probiotics sectors, face challenges in maintaining stability and viability during storage and transportation, leading to reduced efficacy and shelf life. Traditional freeze-drying methods can expose sensitive products to temperature variations and oxygen, further compromising their integrity.
Solution
Lyophitech offers dynamic freeze-drying technology designed to enhance the preservation of sensitive biological products. Their approach involves mixing frozen balls within the freeze dryer to ensure batch homogeneity, even heat distribution, and improved yield of living products. The technology minimizes operator exposure during freezing, freeze-drying, and unloading, enhancing both product and staff safety. This dynamic process ensures optimal quality, properties, and stability of products compared to conventional techniques.
Target Audience
The primary target audience includes companies in the pharmaceutical, microbiology, and probiotics sectors seeking to improve the stability and shelf life of their sensitive biological products.
Features
- Proprietary dynamic freeze-drying technology with multiple patent families
- GMP-adapted machines for the pharmaceutical field
- Homogeneous batch processing through mixing of frozen balls
- Even heat distribution via machine rotation
- Separation of freezing for improved yield of living products
- Contained production process minimizing operator exposure